Norfloxacin
From Wikipedia, the free encyclopedia
Norfloxacin
|
|
Systematic (IUPAC) name | |
1-ethyl-6-fluoro-4-oxo-7-piperazin-1-yl-1H-quinoline- 3-carboxylic acid |
|
Identifiers | |
CAS number | 70458-96-7 |
ATC code | J01MA06 S01AX12 |
PubChem | 4539 |
DrugBank | APRD00469 |
Chemical data | |
Formula | C16H18N3FO3 |
Mol. weight | 319.331 g/mol |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | 3 to 4 hours |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Norfloxacin is an oral broad-spectrum fluoroquinolone antibacterial agent used in the treatment of urinary tract infections.
[edit] Mechanism of action
The mechanism of action of norfloxacin involves inhibition of the A subunit of bacterial DNA gyrase, an enzyme which is essential for DNA replication.[1]
[edit] References
- ^ Goldstein E (1987). "Norfloxacin, a fluoroquinolone antibacterial agent. Classification, mechanism of action, and in vitro activity". Am J Med 82 (6B): 3–17. PMID 3111257.
Quinolones (J01M) edit | ||
---|---|---|
Fluoroquinolones: |
Ciprofloxacin, Enoxacin, Fleroxacin, Gatifloxacin, Gemifloxacin, Grepafloxacin, Levofloxacin, Lomefloxacin, Moxifloxacin, Norfloxacin, Ofloxacin, Pefloxacin, Prulifloxacin, Rufloxacin, Sparfloxacin, Temafloxacin, Trovafloxacin, Sitafloxacin |
|
Other quinolones: |
Cinoxacin, Flumequine, Nalidixic acid, Oxolinic acid, Pipemidic acid, Piromidic acid, Rosoxacin |